3rd Quarter - Report

FABIANI & COMPANY for 3-V BIOSCIENCES, INC.

Period 3rd Quarter 2009 Filed Oct 15, 2009 Signed by Gary Martin, CFO

Official filing
Firm
FABIANI & COMPANY
Client
3-V BIOSCIENCES, INC.
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Pursuing government funding to support therapeutic platform development for infectious diseases

LobbyistCovered position, as disclosed
MELISSA DUPREE —
WENDY SHELTON —

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE

Health Issues HCR

Pursuing government funding to support therapeutic platform development for infectious diseases

LobbyistCovered position, as disclosed
MELISSA DUPREE —
WENDY SHELTON —

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.